Switching from Citalopram to Sertraline

Switching Strategy

The American College of Physicians recommends stopping citalopram 40 mg and starting sertraline 50 mg the next day without any washout period or overlap, as moderate-quality evidence shows no difference in response, remission, or adverse events when switching between SSRIs including citalopram and sertraline 1, 2, 3
This direct switch strategy is supported by clinical trial data demonstrating equivalent safety and efficacy outcomes when transitioning between these specific agents 1, 2

Citalopram has a relatively lower risk of discontinuation syndrome compared to paroxetine, fluvoxamine, and sertraline 4
Discontinuation symptoms can still occur and include dizziness, fatigue, nausea, headaches, insomnia, anxiety, and sensory disturbances 4

No difference in antidepressant response or remission rates should be expected when switching from citalopram to sertraline, based on moderate-quality evidence from randomized trials 1, 2, 3

Switching to another SSRI is a validated second-step strategy with comparable efficacy to other options 1, 2, 3

Moderate-quality evidence demonstrates no difference in response, remission, or adverse events when switching between SSRIs, including citalopram and sertraline, according to the American College of Physicians 5, 6
The standard initial dose of sertraline is 50 mg daily, which can be titrated up to 50-200 mg/day based on clinical response, as recommended by the American Urological Association 7, 8

Sertraline 50 mg is an appropriate starting dose that can be increased if needed after 2-4 weeks, with a typical therapeutic range of 50-200 mg/day 7, 8

Avoid prescribing sertraline to patients with bipolar depression without mood stabilization due to mania risk, as advised by the American Psychiatric Association 7, 8

Watch for serotonin syndrome symptoms, including clonus, tremor, hyperreflexia, agitation, mental status changes, diaphoresis, fever, and severe cases such as seizures and rhabdomyolysis, with low risk when switching appropriately 7, 8

The American College of Physicians recommends switching from one SSRI to another, such as from citalopram to sertraline, as a viable treatment option for patients who do not respond to the initial SSRI, with a similar efficacy and a different side effect profile 9

All SSRIs have similar effect sizes, so the choice of medication is based on side effects and tolerance rather than superior efficacy, according to the Nature Reviews Disease Primers 9
Sertraline is contraindicated with MAO inhibitors and pimozide, and caution is advised when used with other serotonergic agents, triptans, and CNS-active medications 10

Cognitive behavioral therapy (CBT) with exposure and response prevention is particularly effective when available, and can be used in conjunction with pharmacotherapy for optimal outcomes, as noted in the Nature Reviews Disease Primers 9